Corcept Therapeutics Market Sentiment

SPY769.72+0.02%QQQ723.76−0.71%BTC/USD82,061.20+0.60%DIA520.28+0.90%GLD380.95+1.32%TLT80.10+1.53%

Premium

Corcept Therapeutics Inc

CORTNASDAQ

Trade with Public

$113.57

-2.66-2.29%

Last update: Oct 15, 2:18 PM

$115.16

-1.07-0.92%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Corcept Therapeutics Market Sentiment - Benzinga

Corcept Therapeutics Market Sentiment

Market sentiment signals for Corcept Therapeutics (CORT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 10.2% short float

Options Flow▲ 0.16 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

6 analysts

Options Flow (P/C)

0.16

More calls — Bullish

398 calls · 65 puts

Avg Consensus PT

$127

+12.0%

Highest Price Target

$165

+45.3%

Piper Sandler

Lowest Price Target

$50

-56.0%

Wolfe Research

Short Interest

10.2%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 18, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+45.3%	$165 → $165	Maintained	Buy
Jul 30, 2026	Piper Sandler	David Amsellem—	+45.3%	$88 → $165	Maintained	Overweight
Jul 30, 2026	Canaccord Genuity	Edward Nash—	+41.8%	$150 → $161	Maintained	Buy
Jul 30, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+45.3%	$95 → $165	Maintained	Buy
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+32.1%	$135 → $150	Maintained	Buy
Jul 27, 2026	Wolfe Research	Kalpit Patel—	-56.0%	$50	Downgrade	Peer Perform→Underperform
May 28, 2026	Canaccord Genuity	Edward Nash—	+18.9%	$110 → $135	Maintained	Buy
May 28, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-16.4%	$75 → $95	Maintained	Buy
May 13, 2026	UBS	Ashwani Verma—	-36.6%	$44 → $72	Upgrade	Neutral→Buy
May 4, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-34.0%	$60 → $75	Maintained	Buy
May 1, 2026	Piper Sandler	David Amsellem—	-22.5%	$73 → $88	Maintained	Overweight
Mar 26, 2026	Canaccord Genuity	Edward Nash—	-3.1%	$100 → $110	Maintained	Buy
Mar 26, 2026	Wolfe Research	Kalpit Patel—	—	—	Upgrade	Underperform→Peer Perform
Mar 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-47.2%	$67 → $60	Maintained	Buy
Feb 25, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-47.2%	$67 → $60	Maintained	Buy
Feb 20, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-41.0%	$105 → $67	Maintained	Buy
Jan 23, 2026	Canaccord Genuity	Edward Nash—	-11.9%	$99 → $100	Maintained	Buy
Jan 23, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-7.5%	$90 → $105	Maintained	Buy
Jan 2, 2026	Canaccord Genuity	Edward Nash—	-12.8%	$140 → $99	Maintained	Buy
Jan 2, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	-20.8%	$145 → $90	Maintained	Buy
Dec 16, 2025	UBS	Ashwani Verma—	-16.4%	$95	Initiate	Neutral
Nov 25, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+27.7%	$145 → $145	Maintained	Buy
Nov 18, 2025	Wolfe Research	Kalpit Patel—	—	—	Initiate	Peer Perform
Oct 20, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+27.7%	$145 → $145	Maintained	Buy
Oct 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	+27.7%	$145 → $145	Maintained	Buy